期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

马传染性贫血病毒基因表达调节机制的研究进展 被引量：2

下载PDF
导出
作者 梁华 沈弢 张晓燕 邵一鸣
机构地区 中国疾病预防控制中心性病艾滋病预防控制中心病毒免疫室
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2005年第B03期130-132,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 科技部基础研究重大项目前期研究专型(No. 2001CCA00600) 国家自然科学基金资助项目(No. 30371319)
关键词 马传染性贫血病毒 长末端重复序列 增强子 细胞因子
分类号 R373.9 [医药卫生—病原生物学]
  • 相关文献

参考文献19

  • 1Payne SL, Pei XF, Jia B, et al. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus[J]. J Virol, 2004, 78: 2478-2485.
  • 2Maury W, Perryman S, Oaks JL, et al. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus[J]. J Virol, 1997, 71: 4929-4937.
  • 3Hines R, Sorensen BR, Shea MA, et al. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages[J]. J Virol, 2004, 78: 3407-3418.
  • 4Carvalho M, Derse D. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter[J]. J Virol, 1993, 67: 2064-2074.
  • 5Hines R, Maury W. DH82 cells: a macrophage cell line for the replication and study of equine infectious anemia virus[J]. J Virol Methods, 2001, 95: 47-56.
  • 6Zhang XY, Jabrane-Ferrat N, Asiedu CK, et al. The major histocompatibility complex class II promoterbinding protein RFX (NF-X) is a methylated DNA-binding protein[J]. Mol Cell Biol, 1993, 13: 6810-6818.
  • 7Carroll R, Martarano L and Derse D. Identification of lentivirus Tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras[J]. J Virol, 1991, 65: 3460-3467.
  • 8Hoffman D and White S. NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus[J]. Nucleic Acids Res, 1995, 23: 4058-4065.
  • 9Carroll R, Peterlin BM, Derse D. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous transactivators[J]. J Virol, 1992, 66: 2000-2007.
  • 10Maury W, Carpenter S, Graves K, et al. Cellular and viral specificity of equine infectious anemia virus Tat trans-activation[J]. Virology, 1994, 200: 632-642.

同被引文献20

  • 1代春铭,张晓燕,张然然,邵一鸣,沈荣显.重组杆状病毒表达的EIAVEnv蛋白与含有env基因重组痘苗病毒的联合免疫[J].细胞与分子免疫学杂志,2004,20(4):410-414. 被引量：2
  • 2张晓燕,李红梅,梁华,沈弢,马燕,相文华,沈荣显,邵一鸣.EIAV减毒疫苗诱导的特异性细胞免疫应答[J].细胞与分子免疫学杂志,2006,22(1):115-118. 被引量：5
  • 3沈荣显.马传染性贫血病免疫的研究[J].中国农业科学,1979,(4):1-15.
  • 4Chan D C, Fass D, Berger J M, et al. Core structure of gp41 from the HIV envelope glycoprotein[J]. Cell, 1997,89: 263-273.
  • 5Tan K, Liu J, Wang J H, et al. Atomic structure of a thermostable subdomain of HIV-1 gp41 [J]. Proc Natl Acad Sci USA, 1997,94 (23) : 12303-12308.
  • 6Weissenhorn W, Dessen A, Harrison S C, et al. Atomic structure of the ectodomain from HIV-1 gp41[J]. Nature, 1997,387 (6631) : 426-430.
  • 7Home W S, Johnson L M, Ketas T J, et al. Structural and biological mimicry of protein surface recognition by al- pha/beta-peptide foldamers[J]. Proc Natl Acad Sci USA, 2009, 106 (35) : 14751-14756.
  • 8Buzon V, Natrajan G, Schibli D, et al. Crystal structure of HIV-1 gp41 including both fusion peptide and mem- brane proximal external regions [J]. Plos Pathog, 2010, 6 (5) : 880.
  • 9Luftig M A, Mattu M, Di Giovine P, et al. Structural basis for HIV-1 neutralization by a gp41 fusion interme- diate-directed antibody[J]. Nat Struct Mol Biol, 2006, 13 (8) : 740-747.
  • 10Kwong P D, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody [J]. Na- ture, 1998,393 (6686) : 648-659.

引证文献2

二级引证文献6

细胞与分子免疫学杂志
2005年 第B03期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部